August 20, 2020
Home           Membership           Events           Awards           Resources
In This Issue
William R. Huckle, Editor
Join      Rejoin     Renew
Track all things NAVBO

September 9-12, 2020
Online option as well!
Visit the website and register

Join 280 of your colleagues who have already registered!

Vascular Biology 2020
An exciting virtual event
October 26-29, 2020

June 18-22, 2021 - Visit Website

Boston, MA
Postponed until Summer 2021
Corporate Partners

Corporate Member

VB2020 Supporters


VB2020 Exhibitors

VB2020 Guest Societies

Affiliated Journals
Subscription for VBPA
Vascular Biology Publications Alert Now Available by Subscription
The NAVBO Vascular Biology Publications Alert will now be available to non-members for a $55 a year subscription.  If you would like to receive this alert, but are not a member, please contact Danielle at
Grant/Award Opportunity
Shop at Amazon?   
Help Support NAVBO 
Partner Network Advantage on the NAVBO Job Board
Why post your job on NAVBO's career center rather than going directly to the larger job networks?
Pricing on the mass job boards can vary, but to get a job noticed you typically have to sponsor it for $5 - $10 per day, which can add up quickly especially since you also pay for each click the job gets. When you add it all together, you could be spending up to $45 per day on your job posting. But, when posting a job on NAVBO's career center, you simply pay a flat fee! The Premium package includes our Exclusive Extended Partner Network - which means the jobs are broadcast to sites like ZipRecruiter and Jobs2Careers and more for a flat fee.
With special member pricing, you can post a job for as low as $300 with this Partner Network. You never pay for each click, just the flat fee on the NAVBO career center. In addition, the Premium package includes a 60-day job posting making it a great value. The Premium packages also offer features like having your company's logo featured on the career center homepage, having your job appear first in search results, and more.
Post your open position now at!
NAVBO Privacy Policy
Your data privacy and security are important to NAVBO. To that end, we have updated our privacy policy to reflect recent privacy and security regulation implementations and changes. Please review our policy as time permits so you have a complete understanding of the data we have, why we have it, and how we use it.
Part of the updates relate directly to the European Union's new General Data Protection Regulation (GDPR) that went into place May 25,2018.   The GDPR seeks to improve the transparency of data usage and give end users more control over their own data. We believe these changes are important and will be compliant with the GDPR regulations.
Contact NAVBO if you have any questions or to change your communication preferences.
 Please note, you can unsubscribe to this newsletter at anytime by clicking on the SafeUnsubscribe in the footer.
Meet our New Councilor
Daniel M. Greif, M.D.
Dan is Associate Professor with Tenure in Departments of Medicine (Cardiovascular) and Genetics and a cardiologist at Yale. He received B.S. in chemical engineering from Stanford and M.D. from UCSF. Dan took a year off from medical school and conducted research in F. William Luscinskas' lab at Harvard, studying leukocyte-endothelial cell adhesion. He then was a medical resident at University of Washington and at Brigham & Women's Hospital. After residency, he continued at Brigham & Women's Hospital as a postdoc in Thomas Michel's lab, studying biochemistry of eNOS and calmodulin. Dan then returned to Stanford for cardiology fellowship and further postdoctoral training, investigating pulmonary artery morphogenesis in Mark Krasnow's lab.
Dan's lab at Yale utilizes multi-disciplinary approaches to study how blood vessels form, are maintained and go awry in disease. They primarily focus on vascular mural cells (i.e., smooth muscle cells and pericytes). In addition, Dan's lab studies the role of alveolar myofibroblasts in lung development and fibrosis. Furthermore, they investigate how these cell types interface with other cell types, including endothelial and inflammatory cells. Dan's lab aims to gain critical insights into pathogenesis of diverse cardiovascular and pulmonary pathologies and leverage these insights into novel therapeutics to ameliorate human disease.
Dan is committed to engaging young trainees of diverse backgrounds in vascular research and bridging the gap between studies of vascular development and disease to translate fundamental discoveries to human disease. For more information, please visit Dan's lab website: and/or email Dan at:
NAVBO Meritorious Awards - Deadlines Approaching
Submit Nominations:
For the Earl P. Benditt Award and the Judah Folkman Award
Deadlines for nominations are August 31.  Click here for information.

Revisions to existing nominations are due September 7. Contact
Plan to Attend Vascular Biology

  Very excited to be joined by: 
The Microcirculatory Society
and the
American Society for Investigative Pathology

We're looking for volunteers!  When you register indicate that you would like to judge posters and/or moderate a Round Table or Poster Discussion.  Also, tell us what topics you want to discuss in our Round Tables.  
If you already registered, no worries, just let us know via email to

Preliminary program/schedule is available at
Go to for more meeting information.

Tweet this!
Register for Vascular Biology 2020
Looking for a New Position?
Emerging Scientists Series - Add Your Profile!!
Take advantage of this opportunity to showcase your work for would-be employers.  Join Cody on our web site!   

We have heard from a number of people that both graduation ceremonies and thesis presentations have been cancelled and/or reformatted for remote participation.  Coupled with the temporary halt in in-person conferences, this situation may be making it more challenging for trainees to network, promote their science, and search for their next position.  To address this, NAVBO will offer online opportunities for our trainee members.

The new Emerging Scientists Series will offer trainees the opportunity to showcase their thesis research in short research highlight talks.  This new resource will serve as a place for trainees to share their work with employers that are hiring and searching for a new recruit with vascular biology research experience.   Postdocs  - looking for your first faculty position?  You can use this service as well. 
If you are a trainee that has just defended your thesis, or a postdoc seeking your first faculty position and are interested in this opportunity, please contact  
And don't forget to sign up for job alerts in the NAVBO Career Center -
Leaders' Lessons
Leaders' Lessons is on summer hiatus and will return in the fall, featuring wisdom and advice from senior NAVBO members on topics like "How to choose what to pursue scientifically," "Does a research career give second chances?", "How to reinvigorate your research," "What is the right balance between technical personnel and trainees?" and "How to succeed as a physician-scientist."
In the coming months, we want to address YOUR questions - please send your suggestions to Anita.
Senior NAVBO members - we need your help! Please consider investing a few minutes to give back on a grand scale by sharing the lessons you've learned throughout your career with our entire community and in particular, the next generation of vascular biology researchers. Simply respond to one or more of the questions above and send your response to  If you are interested in regularly contributing to Leaders' Lessons, please let Anita know (
Spotlight on Trainees (from August 6 issue)
As fall semester looms, institutions prepare a positive path
Everyone whose lives intersect with life sciences education - students, faculty, staff, family, and more - are eager for a return to familiar patterns of learning, teaching, working, and being. Toward this end, institutions of higher ed have worked hard over the summer to devise plans for opening fall 2020 studies in a manner that is safe, productive, and inspire the confidence and compliance of all involved. Particulars of these plans differ according to institutional culture and prevailing local public health considerations, but they each make an earnest appeal to the team spirit of their diverse communities, with reminders of mutual responsibilities to colleagues as well as oneself. The only win is one that we all share.
Member News
Welcome to our New Members:
Bipul Acharya, University of Virginia, School of Medicine
Arulselvi Anbalagan, University of Pittsburgh
Erika Arias, Northwestern
Steven Bothwell, University of Newcastle, Australia
Steven Botts, University Health Network
Jean Bouchart, Yale SOM
Allison Brichacek, West Virginia University Health Sciences
Susann Bruche, University of Oxford
Jeremy Burton, University of Georgia
Zarek Burton, Washington University in St. Louis
Katelyn Cabral, University of California, San Francisco
Crizza Ching, Toronto General Hospital Research Institute
Kirsten Coupland, University of Newcastle
Sarah De Val, University of Oxford
Elise Drapé, Université de Montréal
Fan Fan, University of Mississippi Medical Center
Yohan Farouz, Roche
Tao Fu, Northwestern University
Annette Gonzalez, Northwestern University
Haote Han, Schepens Eye Research Institute
Donny Hanjaya-Putra, University of Notre Dame
Vanessa Hayashi, Feinberg School of Medicine
Jose Luis Herrera, Johns Hopkins University
Maruf Hoque, Virginia Tech
Zhenyu Ji, Schepens Eye Research Institute
Xinguo Jiang, VA Palo Alto/Stanford University
Alexandra Kaloss, Virginia Tech
Hwan Kim, Boston Children's Hospital
Ramoji Kosuru, Versiti Blood Research Institute
Rok Krese, Roche
Rathnakumar Kumaragurubaran, Indian Institute of Technology Madras
Johanna Laakkonen, University of Eastern Finland
Nadège Lagarde, Roche
Dianne Langford, Lewis Katz School of Medicine at Temple University
Salwa Lin, University of Oxford
Yedan Liu, The University of Mississippi Medical Center
Melissa Luse, University of Virginia
Matthijs Luxen, UMCG
Jisca Majolee, Amsterdam UMC
Ariel Mei, Tufts Medical Center
Qing Miao, NYU Winthrop Hospital
Neil Nadkarni, Northwestern University Feinberg School of Medicine
Magdalena Nakova, Roche
Ingrid Nilsson, Karolinska Institute
Akshar Patel, University at Buffalo
Paramita Pati, University of Alabama at Birmingham
Samuel Roach, University of Illinois at Chicago College of Meidicine
Daniella Rogerson, Columbia University Irving Medical Center
Anara Serikbaeva, University of Illinois at Chicago
Julie Sesen, Boston Children's Hospital
Guru Prasad Sharma, Blood Reserch Institute, Wisconsin
Takuro Shirasu, The University of Virginia
Chiara Testini, Boston Children's Hospital
Stanislao Travisano, CHLA
Michael Udin, University at Buffalo, SUNY
Maria Ulvmar, Uppsala University
Jasmina Varagic, NIH/NHLBI
Marina Venero Galanternik, NICHD, NIH
Remi Villenave. Roche
Atay Vural, Koç University
Kirby Warren, University of Newcastle
Reiner Wimmer, Roche
Ruilin Wu, University Health Network
Xiujie Xie, University of Virginia
Tamara Zimmermann, Roche
If you have news to share with your colleagues, send it to
Recent Publications by NAVBO Members
Missing Midline Metatarsals Conform to Plantar Arterial Arch Dysgenesis 
Journal of the American Podiatric Medical Association
Midline metatarsal ray deficiencies, which occur in approximately half of congenital short limbs with fibular deficiency, provide the most distal and compelling manifestation of a fluid spectrum of human lower-extremity congenital long bone reductions; this spectrum syndromically affects the long bone triad of the proximal femur, fibula, and midline metatarsals.   Read more

TMEM100 is a key factor for specification of lymphatic endothelial progenitors 
Background: TMEM100 is identified as a downstream gene of bone morphogenetic protein 9 (BMP9) signaling via activin receptor-like kinase 1 (ALK1), which is known to participate in lymphangiogenesis as well as angiogenesis.   Read more
Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models Of Hereditary Hemorrhagic Telangiectasia 
Circulation Research
Rationale: Hereditary hemorrhagic telangiectasia (HHT) is a genetic disease caused by mutations in ENG, ALK1, or SMAD4. Since proteins from all three HHT genes are components of signal transduction of TGF-β family members, it has been hypothesized that HHT is a disease caused by defects in the ENG-ALK1-SMAD4 linear signaling.  Read more
Local Mitochondrial ATP Production Regulates Endothelial Fatty Acid Uptake and Transport 
Cell Metabolism
Most organs use fatty acids (FAs) as a key nutrient, but little is known of how blood-borne FAs traverse the endothelium to reach underlying tissues. We conducted a small-molecule screen and identified niclosamide as a suppressor of endothelial FA uptake and transport.  Read more
Editorial: Where Is Waldo: Contextualizing the Endothelial Cell in the Era of Precision Biology 
Frontiers in Cardiovascular Medicine
Many readers may recall Waldo, the North American version of the original character of "Where is Wally?" introduced in 1987 by British author Martin Handford.  Read more
Industry News (from August 6 issue)
NIH stresses flexibility in awardees meeting compliance requirements
A recent 'Open Mike' feature on the NIH's Extramural Nexus describes administrative flexibilities that NIH, mindful of COVID-related challenges, is extending to research institutions with active laboratory animal programs. These accommodations aim to maintain expected personnel safety and animal welfare while allowing investigators to sustain their research efforts. For example, the Office of Laboratory Animal Welfare has granted temporary waivers to semiannual inspections. Other flexibilities, such as the ability of IACUCs to conduct business virtually, are always available to institutions but may be particularly useful during pandemics. Many unanswered questions remain; investigators are encouraged to reach out to OLAW with queries on related topics.  
COVID-19 casts shadow on seeking care for myocardial infarction
Salvatore De Rosa and colleagues report in the European Heart Journal on the impact of the COVID-19 pandemic on patient admissions to Italian cardiac care units for diagnosis of suspected acute myocardial infarction. The study, a multicenter, observational survey, collected data on admissions for AMI at Italian cardiac care units in a 1-week period during the COVID-19 outbreak compared with the equivalent week in 2019. Admissions for AMI were reduced by 48.4%, with significant drops for both ST-segment elevation MI and non-STEMI. The STEMI case fatality rate during the pandemic test window was markedly increased compared with 2019 (risk ratio 3.3). The authors note that their findings reflect a serious social issue that warrants attention by the healthcare and public regulatory communities.  
AAMC plans November e-conference on medical education and health care delivery
The American Association of Medical Colleges has announced plans for Learn Serve Lead 2020, the organization's signature event focused on academic medicine's present and future. The agenda will examine how COVID-19 has changed the medical school experience and the operation of teaching hospitals, against the backdrop of persistent racial inequities both in society and within health care. Confirmed speakers include Ibram X. Kendi, PhD, Nikole Hannah-Jones, Francis Collins, MD, PhD, Anne Schuchat, MD, and Anthony Fauci, MD. The virtual gathering is scheduled for Nov. 16-18, 2020; registration opens in August.
Call for Papers
Frontiers in Cardiovascular Medicine
Special Research Topics

Putting Engineering Back In Vascular Tissue Engineering To Advance Basic Science and Clinical Applications
Topic Editors:  Jessica Wagenseil (Washington University in St. Louis) and W. Lee Murfee (University of Florida).

This topic is sponsored by NAVBO
Vascular tissue engineering (VTE) can be characterized as the creation of replacement vessels. Over the past 30 years, approaches have incorporated different combinations of extracellular matrix scaffolds, cells and biological active chemical cues. Challenged by the goal to recapitulate the complexity of big or small vessels, the clinical use of in vitro tissue engineered vessel replacements is still limited. With research more often focusing on reductionist materials science or cell biology characterization of vessel-like constructs, an opportunity has emerged to re-apply engineering approaches to guide the next step in VTE. 

Submit your manuscript by October 17, 2020
For more information, click here  

What do we know about COVID-19 implications for cardiovascular disease?
Topic Editors: Hendrik Tevaearai Stahel, Masanori Aikawa, Shuyang Zhang, and Andrew F. James 
The coronavirus epidemic causes major cardiovascular complications. Underlying mechanisms, however, remain incompletely understood. Frontiers in Cardiovascular Medicine invite you to submit your article on this topic. We consider all types of manuscripts: fundamental basic science reports, translational or clinical studies, review articles and methodology papers.
Submit your manuscript by August 28, 2020
For more information, click here 
For questions, please contact Masanori Aikawa or the editorial office

Comorbidities and aortic valve stenosis - molecular mechanism, risk factors and novel therapeutic options
Topic Editors: Claudia Goettsch, Felix Jansen and Cynthia St. Hilaire

Aortic valve stenosis (AS) is the most prevalent valvular heart disease of the elderly population in the developed world, and the disease burden is estimated to increase from 2.5 million in 2000 to 4.5 million in 2030. Comorbidities like hypertension, type 2 diabetes mellitus, dyslipidemia, chronic kidney disease, COPD, chronic inflammatory diseases, and anemia are highly prevalent in this population. They not only influence the clinical course of AS and its prognosis, but affect therapeutic success.

Submit your abstract by September 15, 2020
For more information, click here
Dear friends and colleagues,
 Jun Zhang, PhD (Associate Professor, Texas Tech University Health Sciences Center El Paso), is organizing a special issue entitled "Advancements in Cerebral Cavernous Malformations" in journal Vessel Plus (VP, ISSN 2574-1209).
This special issue aims to bring readers the up-to-date view of advancements in the scientific and technology innovations, translational and basic-science studies, and clinical trials of cerebral cavernous malformations. For more details about this special issue and the "Author Instructions", please visit the website at
Are you interested in contributing an article before February 15, 2021? If yes, please contact Jun Zhang (, the Guest Editor for this special issue, or Mavis Wei (, the Managing Editor of VP. If you need additional information, please feel free to contact us.
VP is an online open access journal which was launched on March 31, 2017 by OAE Publishing Inc.  It waives the Article Processing Charge (APC) for all publications since launched. Thus, your manuscripts will be published totally free of charge once officially accepted after quick and rigorous peer-review. Meanwhile, all manuscripts published in VP will be immediately available online for free downloading and reading. Further, if the work is funded by NIH, we can deposit it in PubMed on your behalf.
Thank you for considering this invitation.
Dear friends and colleagues,

Ramani Ramchandran, PhD (Professor, Medical College of Wisconsin), is organizing a special issue entitled "The Road (Genes, Proteins, RNAs, and Signaling Pathways) Less Travelled in Vascular Biology" in journal Vessel Plus (VP, ISSN 2574-1209).
This special issue aims to provide readers with an up-to-date advancement in lesser-known genes, proteins and signaling pathways in vascular biology. Manuscripts related to concepts from these genes and proteins and their associated signaling pathways that connect into the well-established vascular ligand-receptor signaling systems are welcome. For more details about this special issue and the "Author Instructions", please visit the website at
Are you interested in contributing an article before December 31, 2020? If yes, please contact Ramani Ramchandran (, the Guest Editor for this special issue, or Mavis Wei (, the Managing Editor of VP. If you need additional information, please feel free to contact us.
VP is an online open access journal which was launched on March 31, 2017 by OAE Publishing Inc. It waives the Article Processing Charge (APC) for all publications since launched. Thus, your manuscripts will be published totally free of charge once officially accepted after quick and rigorous peer-review. Meanwhile, all manuscripts published in VP will be immediately available online for free downloading and reading. Further, if the work is funded by NIH, we can deposit it in PubMed on your behalf.
Thank you for considering this invitation.
Job Postings
Calendar of Events
Sept. 9 - 12, 2020
21st International Vascular Biology Meeting (IVBM 2020)
Oct. 3 - 6, 2020
11th Kloster Seeon Angiogenesis Meeting (postponed until September 2021)
Oct. 26 - 29, 2020
Vascular Biology 2020 - A Virtual Experience
Nov. 16 - 18, 2020
EMBO Workshop - Cell Signalling and Biology of Vascular Malformations
June 18 - 22, 2021
Lymphatic Forum 2021
North American Vascular Biology Organization | |
18501 Kingshill Road
Germantown, MD 20874-2211